Effect of Diltiazem on the Pharmacokinetics of BMS-914392 and on Heart Rate After Single-dose Administration of BMS-914392 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 20 Jan 2016
At a glance
- Drugs NTC 801 (Primary) ; Diltiazem
- Indications Angina pectoris; Atrial fibrillation; Hypertension; Supraventricular tachycardia; Unstable angina pectoris; Variant angina pectoris
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 17 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 08 Oct 2010 New trial record